Does RANOLAZINE Cause Cardiomyopathy? 10 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Cardiomyopathy have been filed in association with RANOLAZINE (Ranolazine). This represents 0.1% of all adverse event reports for RANOLAZINE.
10
Reports of Cardiomyopathy with RANOLAZINE
0.1%
of all RANOLAZINE reports
4
Deaths
6
Hospitalizations
How Dangerous Is Cardiomyopathy From RANOLAZINE?
Of the 10 reports, 4 (40.0%) resulted in death, 6 (60.0%) required hospitalization.
Is Cardiomyopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANOLAZINE. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does RANOLAZINE Cause?
Death (692)
Myocardial infarction (610)
Stent placement (593)
Chest pain (592)
Angina pectoris (583)
Dizziness (517)
Dyspnoea (348)
Cerebrovascular accident (334)
Fall (299)
Off label use (270)
What Other Drugs Cause Cardiomyopathy?
DOXORUBICIN (820)
CYCLOPHOSPHAMIDE (581)
SACUBITRIL\VALSARTAN (444)
CLOZAPINE (404)
PREDNISONE (379)
RITUXIMAB (379)
ROSIGLITAZONE (374)
VINCRISTINE (326)
TRASTUZUMAB (292)
HYDROXYCHLOROQUINE (231)
Which RANOLAZINE Alternatives Have Lower Cardiomyopathy Risk?
RANOLAZINE vs RAPAMUNE
RANOLAZINE vs RASAGILINE
RANOLAZINE vs RASBURICASE
RANOLAZINE vs RAVULIZUMAB
RANOLAZINE vs RAVULIZUMAB-CWVZ